- About Us
- Innovation Park
- Technology Transfer
- Business Assistance
- Policies and Regulations
- See Missouri S&T Technologies
- Search UM System Technologies
- Contact Us
Mo-Sci Corporation Licenses Wound Care Technology From Missouri S&T
Mo-Sci Corporation, a Rolla, Missouri-based advanced materials company that produces glass-based materials for various uses including medical applications, recently licensed technology from Missouri University of Science and Technology (Missouri S&T) for use in wound care. The cotton candy-like glass fiber material helps speed the healing of venous stasis wounds.
As reported in ScienceDaily®, Phelps County Regional Medical Center began an empirical study of the material in the fall of 2010. The study comprised 12 volunteers all of whom had wounds that had been unhealed for more than a year with one patient having an unhealed wound for three years. The skin was repaired in 8 of the participants after using the glass fiber product for a few months. The wounds of the other four participants showed significant progress and were expected to heal also.
Bioglass materials aren't particularly new to the medical field. They are normally formed from a silica-based glass composition and have primarily been used in hard-tissue regeneration, such as bone repair. According to glass scientist Dr. Steve Jung, who co-developed the technology with Dr. Delbert Day while obtaining his Ph.D. from Missouri S&T, there had been speculation as to whether or not a different type of bioactive glass material could be used for soft-tissue regeneration. "We felt from our in-vitro studies that bioactive glasses containing boron would react to body fluids much faster than silicate glasses," says Jung.
The low cost, easy to use material, which Mo-Sci has branded as DermaFuse™, is made of a borate glass composition, call 13-93B3, formed into cotton-like glass fibers. The material is packed into open wounds and provides a healing scaffold for the body. Jung and Day believe that the material works by trapping blood platelets and allowing the formation of a wound cover that supports the healing process. It also seems to minimize the amount of scarring. As the body heals, the material is absorbed by the body and disappears over time.
“We are very excited about the possibilities of this technology,” says Keith Strassner, director of the Office of Technology Transfer and Economic Development (TTED) at Missouri S&T. “Mo-Sci is a long time partner of Missouri S&T and we’re confident that their efforts to commercialize this technology will result in a huge leap forward in wound care treatment.” Interested parties may contact Mr. Eric Anderson by email at email@example.com for information about this technology or other Missouri S&T innovations.
TTED serves as the focal point for technology commercialization, entrepreneurship, business development, and economic development at Missouri S&T. Its mission is to grow Missouri's economy by advancing technology commercialization, encouraging entrepreneurship, and promoting business opportunities. Missouri S&T is part of the University of Missouri system. It is Missouri’s premier science, engineering, and technology university and one of the top technological research universities in the nation. Additional information about TTED can be found online at http://ecodevo.mst.edu.
Mr. Eric Anderson
Senior Business Development and Licensing Associate
Office of Technology Transfer and Economic Development
Missouri University of Science and Technology